|
IL28RA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.65380000050864E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01770000004997E-06 |
| Normal-vs-Stage2 |
2.04879999999852E-05 |
| Normal-vs-Stage3 |
8.30249999972388E-07 |
| Normal-vs-Stage4 |
2.233800E-04 |
| Stage1-vs-Stage2 |
5.828200E-01 |
| Stage1-vs-Stage3 |
2.945600E-01 |
| Stage1-vs-Stage4 |
5.582600E-01 |
| Stage2-vs-Stage3 |
6.934400E-01 |
| Stage2-vs-Stage4 |
6.903800E-01 |
| Stage3-vs-Stage4 |
9.340600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.97910000002233E-07 |
| Normal-vs-AfricanAmerican |
1.17949999989264E-07 |
| Normal-vs-Asian |
2.341200E-03 |
| Caucasian-vs-AfricanAmerican |
7.703400E-01 |
| Caucasian-vs-Asian |
3.811200E-01 |
| AfricanAmerican-vs-Asian |
7.084800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.98294763626473E-12 |
| Normal-vs-Female |
2.460200E-02 |
| Male-vs-Female |
1.016310E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.985560E-04 |
| Normal-vs-Extreme_Weight |
5.01860000001741E-07 |
| Normal-vs-Obese |
1.28169999946692E-07 |
| Normal-vs-Extreme_Obese |
1.760720E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.281400E-01 |
| Normal_Weight-vs-Obese |
4.868600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.138800E-01 |
| Extreme_Weight-vs-Obese |
9.361200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.213400E-01 |
| Obese-vs-Extreme_Obese |
5.499800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.438000E-03 |
| Normal-vs-Age(41-60Yrs) |
5.58109999999612E-05 |
| Normal-vs-Age(61-80Yrs) |
4.20060000116962E-08 |
| Normal-vs-Age(81-100Yrs) |
3.77209999999906E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.371000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.359200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.412000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.300770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.491780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.515200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.45259999995151E-06 |
| Normal-VS-Type2 PRCC |
3.97220034642487E-11 |
| Normal-VS-KIRP CIMP |
1.825930E-02 |
| Normal-VS-Unclassified PRCC |
1.46840000003756E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.422400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.259400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.215200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.981800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.241610E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.784800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59599999882687E-08 |
| Normal-vs-N1 |
2.96550000000728E-06 |
| Normal-vs-N2 |
1.034410E-02 |
| N0-vs-N1 |
7.119200E-01 |
| N0-vs-N2 |
5.879400E-01 |
| N1-vs-N2 |
7.594600E-01 |
|
|
